ES488168A0 - Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada. - Google Patents

Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.

Info

Publication number
ES488168A0
ES488168A0 ES488168A ES488168A ES488168A0 ES 488168 A0 ES488168 A0 ES 488168A0 ES 488168 A ES488168 A ES 488168A ES 488168 A ES488168 A ES 488168A ES 488168 A0 ES488168 A0 ES 488168A0
Authority
ES
Spain
Prior art keywords
active
tablets
default
pharmaceutical
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES488168A
Other languages
English (en)
Other versions
ES8102702A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Publication of ES488168A0 publication Critical patent/ES488168A0/es
Publication of ES8102702A1 publication Critical patent/ES8102702A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES488168A 1979-02-02 1980-02-01 Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada. Expired ES8102702A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI790350A FI63335B (fi) 1979-02-02 1979-02-02 Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne

Publications (2)

Publication Number Publication Date
ES488168A0 true ES488168A0 (es) 1981-02-16
ES8102702A1 ES8102702A1 (es) 1981-02-16

Family

ID=8512353

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488168A Expired ES8102702A1 (es) 1979-02-02 1980-02-01 Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.

Country Status (15)

Country Link
US (1) US4351825A (es)
EP (1) EP0014514B1 (es)
JP (1) JPS55129222A (es)
AR (1) AR222207A1 (es)
AT (1) ATE20182T1 (es)
CA (1) CA1144071A (es)
DE (1) DE3071625D1 (es)
DK (1) DK28480A (es)
ES (1) ES8102702A1 (es)
FI (1) FI63335B (es)
GR (1) GR65623B (es)
IE (1) IE51741B1 (es)
NO (1) NO149490B (es)
PT (1) PT70719A (es)
ZA (1) ZA80553B (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
US4927633A (en) * 1984-03-19 1990-05-22 Alza Corporation Dispenser for delivering drug to livestock
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
US5000957A (en) * 1984-03-19 1991-03-19 Alza Corporation Dispenser comprising hydrophilic osmopolymer
US4729793A (en) * 1985-08-09 1988-03-08 Alza Corporation Composition for manufacturing wall of dispensing device
US4624945A (en) * 1984-03-19 1986-11-25 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US4844984A (en) * 1984-03-19 1989-07-04 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
FR2573307B1 (fr) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog Implants anabolisants a liberation prolongee
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
IT1204294B (it) * 1986-03-11 1989-03-01 Gentili Ist Spa Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
WO1989009066A1 (en) * 1988-03-24 1989-10-05 Bukh Meditec A/S Controlled release composition
US6056992A (en) * 1988-06-02 2000-05-02 Campbell Soup Company Encapsulated additives
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
IL96311A (en) † 1989-12-01 1995-05-26 Abbott Lab Medications with delayed release
GB9015822D0 (en) * 1990-07-18 1990-09-05 Beecham Group Plc Compositions
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US5431630A (en) * 1993-09-07 1995-07-11 Surgic-Acid, Inc. Needle guard and nonreusable syringe
US6103262A (en) * 1994-01-27 2000-08-15 G. D. Searle & Company Modified-release metronidazole compositions and methods for making and using same
US5484608A (en) * 1994-03-28 1996-01-16 Pharmavene, Inc. Sustained-release drug delivery system
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US6776996B2 (en) 1997-07-09 2004-08-17 Basf Aktiengesellschaft Pesticidal matrices
ID20839A (id) * 1997-07-09 1999-03-11 American Cyanamid Co Bahan acuan pestisida berlapis lebih baik, pengolahan pada pembuatannya serta komposisi-komposisi yang terkandung di dalamnya
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
EP2332522A3 (en) 1998-03-19 2011-12-07 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
EP1949890A3 (en) 1999-06-04 2011-05-18 ALZA Corporation Implantable gel compositions and method of manufacture
MXPA01012471A (es) * 1999-06-04 2002-07-30 Alza Corp Composiciones de gel implantables y metodo de fabricacion..
US6676966B1 (en) 2000-05-09 2004-01-13 Intellipharmaceutics Corp. Extended release metformin hydrochloride formulations
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
DE10127134A1 (de) * 2001-06-05 2002-12-12 Roehm Gmbh verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
EP1515701B1 (en) 2002-06-17 2014-09-17 Inventia Healthcare Private Limited Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide
EP1549296A4 (en) * 2002-08-02 2006-08-09 Penwest Pharmaceuticals Co METFORMIN FORMULATIONS WITH DELAYED RELEASE
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
PE20060003A1 (es) 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
KR102328603B1 (ko) 2016-12-08 2021-11-18 알.피.쉐러 테크놀러지즈 엘엘씨 파손 가능성을 감소시키기 위해 캡슐 쉘 내의 응력을 완화시키는 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
SE353229B (es) * 1970-06-04 1973-01-29 Haessle Ab
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS6191314A (ja) * 1984-10-12 1986-05-09 Nippon Kokan Kk <Nkk> 取鍋精錬炉による溶鋼の精錬方法

Also Published As

Publication number Publication date
JPS55129222A (en) 1980-10-06
FI63335B (fi) 1983-02-28
DK28480A (da) 1980-08-03
EP0014514A2 (en) 1980-08-20
US4351825A (en) 1982-09-28
NO794290L (no) 1980-08-05
IE51741B1 (en) 1987-03-18
CA1144071A (en) 1983-04-05
AR222207A1 (es) 1981-04-30
FI790350A (fi) 1980-08-03
GR65623B (en) 1980-10-15
IE800202L (en) 1980-08-02
EP0014514A3 (en) 1981-06-10
NO149490B (no) 1984-01-23
DE3071625D1 (en) 1986-07-10
PT70719A (en) 1980-02-01
ES8102702A1 (es) 1981-02-16
ZA80553B (en) 1981-02-25
ATE20182T1 (de) 1986-06-15
EP0014514B1 (en) 1986-06-04

Similar Documents

Publication Publication Date Title
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
ES2159591T3 (es) Composicion de liberacion controlada.
DK155776C (da) Laegemiddelafgivningsorgan med forlaenget frigoering af laegemiddel, og fremgangsmaade til dets fremstilling
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
BE808519A (fr) Medicament pour relachement entretenu d&#39;un ingredient actif et methode d&#39;utilisation de ce medicament
FI820467L (fi) Farmaceutiska kompositioner som frigoers kontinuerligt
ES2027637T3 (es) Procedimiento para preparar una composicion efervescente que contiene ibuprofeno.
DK156375C (da) Praeparater til oral administration til droevtyggere med langvarig medikamentafgivelse
NO146456C (no) Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel
MY107088A (en) Plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release,process for the production of the plaster and use thereof
ES2021028B3 (es) Dispositivo para liberacion de farmacos en 2 etapas.
ES2034035T3 (es) Procedimiento de preparacion de una forma farmaceutica para la administracion y/o dosificacion de medicamentos.
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
DK0421541T3 (da) Tabletstruktur, som kan deles
ES277844Y (es) Una disposicion de punta de dosificacion para administrar una dosis de medicamento, alimentos, vitaminas o similares, a un paciente
AR002972A1 (es) Pildoras que tienen una matriz farmaceutica que proporcionan un perfil apropiado de liberacion de la droga, composicion para la preparacion de dichamatriz, proceso para preparar dichas pildoras y formas de dosificacion de dicha composicion.
IT8020100A0 (it) Medicamento, o preparato farmaceutico, ad azione citostatica.
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
CA937866A (en) Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
BE839309A (fr) Nouvel antibiotique, sa preparation et medicament le contenant
BE804850A (fr) Indolyl-alkylamines, leur preparation et medicament contenant ces substances
BE820593Q (fr) 4,4-diaryl-piperidines, preparation de ces substances et les medicaments dans lesquels elles figurent comme matiere active.
GB1110397A (en) Ephedrine composition
GB976096A (en) Pharmaceutical compositions
BE838243A (fr) Nouvelles amidines, leur procede de preparation et medicament les contenant

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010217